LLYEli Lilly and Company

$126.13
$-3.06 (-2%)

Eli Lilly and Company (LLY) Stock Analysis

Create a FREE Account to View Full LLY Stock Report

Eli Lilly and Company (LLY) Analyst Forecast

Next 12 months ➝Current Price$126.1352-week High$147.8752-week Low$101.36MEAN$146.00+15.75%HIGH$156.00+23.68%LOW$133.00+5.45%
  • Last Price$126.13
  • Previous Close$129.19
  • Change $-3.06
  • Open$126.38
  • Volume7,873,999
  • Avg. Volume (100-day)3,380,461
  • Market Capitalization$120.63B
  • Days Range $121.51 - $126.80
  • 52-week Range $101.36 - $147.87
  • Dividend Yield2.29%
  • Ex. Dividend Date02/13/2020
  • P-E14.7
  • EPS8.77
  • Earnings Date05/05/2020
  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • Avg. Analyst Rec.
  • Beta0.789
  • PEG Ratio1.69
  • Volatility0.41
  • Average True Range0.02
Eli Lilly is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Forteo for osteoporosis; Jardiance, Trulicity, Humalog, and Humulin for diabetes; Taltz and Olumiant for immunology; and Cialis for erectile dysfunction.